Business Description
Advicenne SA
ISIN : FR0013296746
Compare
Compare
Traded in other countries / regions
ALDVI.France3MM.Germany IPO Date
2021-04-16Description
Advicenne SA is a late-stage biopharmaceutical company. The company is engaged in the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications. Its goal is to improve the lives of patients from early childhood through adulthood.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | -2.19 | |||||
| Debt-to-Equity | -1.01 | |||||
| Debt-to-EBITDA | -2.77 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.59 | |||||
| Beneish M-Score | -2.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.4 | |||||
| 3-Year EBITDA Growth Rate | 28.6 | |||||
| 3-Year EPS without NRI Growth Rate | 27.1 | |||||
| 3-Year FCF Growth Rate | 21.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 40.66 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 27.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.81 | |||||
| 9-Day RSI | 42.36 | |||||
| 14-Day RSI | 42.03 | |||||
| 3-1 Month Momentum % | -0.2 | |||||
| 6-1 Month Momentum % | 81.82 | |||||
| 12-1 Month Momentum % | 70.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.36 | |||||
| Quick Ratio | 0.26 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 280.95 | |||||
| Days Sales Outstanding | 174.22 | |||||
| Days Payable | 188.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.9 | |||||
| Shareholder Yield % | 4.14 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.53 | |||||
| Operating Margin % | -245.02 | |||||
| Net Margin % | -264.13 | |||||
| FCF Margin % | -168.08 | |||||
| ROA % | -85.23 | |||||
| ROIC % | -90.27 | |||||
| 3-Year ROIIC % | -140.81 | |||||
| ROC (Joel Greenblatt) % | -394.21 | |||||
| ROCE % | -118.51 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6.23 | |||||
| EV-to-EBIT | -4.61 | |||||
| EV-to-EBITDA | -5.89 | |||||
| EV-to-Revenue | 11.16 | |||||
| EV-to-FCF | -6.81 | |||||
| Price-to-GF-Value | 0.33 | |||||
| Earnings Yield (Greenblatt) % | -21.72 | |||||
| FCF Yield % | -24.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Advicenne SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.343 | ||
| EPS (TTM) (€) | -0.747 | ||
| Beta | 0.25 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.03 | ||
| Volatility % | 159.26 | ||
| 14-Day RSI | 42.03 | ||
| 14-Day ATR (€) | 0.070814 | ||
| 20-Day SMA (€) | 1.8346 | ||
| 12-1 Month Momentum % | 70.43 | ||
| 52-Week Range (€) | 0.794 - 2.795 | ||
| Shares Outstanding (Mil) | 12.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Advicenne SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Advicenne SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Advicenne SA Frequently Asked Questions
What is Advicenne SA(STU:3MM)'s stock price today?
The current price of STU:3MM is €1.75. The 52 week high of STU:3MM is €2.80 and 52 week low is €0.79.
When is next earnings date of Advicenne SA(STU:3MM)?
The next earnings date of Advicenne SA(STU:3MM) is .
Does Advicenne SA(STU:3MM) pay dividends? If so, how much?
Advicenne SA(STU:3MM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers